Symbols / OGEN $0.60 -1.21% Oragenics, Inc.
OGEN Chart
Stock Fundamentals
|
|
|
|
|
|
About
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
Ratings
Current target
$0.58
Low
—
High
—
Mean
—
- OGEN Stock Price, Quote & Chart | ORAGENICS INC (NYSEARCA:OGEN) - ChartMill Fri, 24 Apr 2026 07
- $OGEN stock is down 10% today. Here's what we see in our data. | OGEN Stock News - Quiver Quantitative Wed, 11 Mar 2026 07
- Concussion has no approved drug; Oragenics doses 2 in trial - Stock Titan Mon, 20 Apr 2026 13
- Telling Fred sells Oragenics (OGEN) shares for $198 - Investing.com hu, 22 Jan 2026 08
- Oragenics shares plunge following announcement of $20 million preferred stock sale - MSN Sun, 26 Apr 2026 05
- Can Oragenics (OGEN) Stock Rebound in 2026 | Price at $0.61, Up 8.48% - Buy Signals - Cổng thông tin điện tử Tỉnh Sơn La Mon, 06 Apr 2026 07
- OGEN News | ORAGENICS INC (NYSEARCA:OGEN) - ChartMill Fri, 24 Apr 2026 07
- $OGEN stock is down 9% today. Here's what we see in our data. - Quiver Quantitative hu, 22 Jan 2026 08
- Why Is Oragenics Stock (OGEN) Down 55% Today? - TipRanks ue, 01 Jul 2025 07
- Oragenics previews targeted milestones for 2026 - Yahoo Finance ue, 10 Feb 2026 08
- symbol__ Stock Quote Price and Forecast - CNN hu, 08 Feb 2024 18
- Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants - GlobeNewswire ue, 01 Jul 2025 07
- [EFFECT] ORAGENICS INC SEC Filing - Stock Titan Sun, 22 Mar 2026 07
- Oragenics stock tumbles after announcing $20 million preferred stock offering - Investing.com ue, 01 Jul 2025 07
- Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split - Yahoo Finance Wed, 28 May 2025 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
9.36
-11.33%
|
10.56
-49.49%
|
20.90
+44.96%
|
14.42
|
| Research And Development |
|
2.39
-41.85%
|
4.11
-73.44%
|
15.49
+53.79%
|
10.07
|
| Selling General And Administration |
|
6.97
+8.15%
|
6.44
+18.20%
|
5.45
+21.71%
|
4.48
|
| General And Administrative Expense |
|
6.97
+8.15%
|
6.44
+18.20%
|
5.45
+21.71%
|
4.48
|
| Other Gand A |
|
6.97
+8.15%
|
6.44
+18.20%
|
5.45
+21.71%
|
4.48
|
| Other Operating Expenses |
|
—
|
—
|
-0.04
+71.37%
|
-0.13
|
| Total Expenses |
|
9.36
-11.33%
|
10.56
-49.49%
|
20.90
+44.96%
|
14.42
|
| Operating Income |
|
-9.36
+11.33%
|
-10.56
+49.49%
|
-20.90
-44.96%
|
-14.42
|
| Total Operating Income As Reported |
|
-9.36
+11.33%
|
-10.56
+49.49%
|
-20.90
-44.96%
|
-14.42
|
| EBITDA |
|
-9.19
+12.76%
|
-10.54
+48.84%
|
-20.60
-44.76%
|
-14.23
|
| Normalized EBITDA |
|
-9.18
+12.68%
|
-10.51
+48.96%
|
-20.60
-44.76%
|
-14.23
|
| Reconciled Depreciation |
|
—
|
0.00
-100.00%
|
0.03
-38.68%
|
0.04
|
| EBIT |
|
-9.19
+12.76%
|
-10.54
+48.91%
|
-20.63
-44.50%
|
-14.27
|
| Total Unusual Items |
|
-0.01
+47.59%
|
-0.03
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-0.01
+47.59%
|
-0.03
|
—
|
—
|
| Net Income |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Pretax Income |
|
-9.98
+5.57%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Net Non Operating Interest Income Expense |
|
-0.60
-3856.93%
|
0.02
-91.06%
|
0.18
+48.85%
|
0.12
|
| Interest Expense Non Operating |
|
0.79
+2534.87%
|
0.03
-2.49%
|
0.03
+102.55%
|
0.02
|
| Net Interest Income |
|
-0.60
-3856.93%
|
0.02
-91.06%
|
0.18
+48.85%
|
0.12
|
| Interest Expense |
|
0.79
+2534.87%
|
0.03
-2.49%
|
0.03
+102.55%
|
0.02
|
| Interest Income Non Operating |
|
0.18
+297.04%
|
0.05
-78.19%
|
0.21
+54.82%
|
0.14
|
| Interest Income |
|
0.18
+297.04%
|
0.05
-78.19%
|
0.21
+54.82%
|
0.14
|
| Other Income Expense |
|
-0.01
+47.59%
|
-0.03
-136.29%
|
0.07
+498.89%
|
0.01
|
| Other Non Operating Income Expenses |
|
—
|
—
|
0.07
+498.89%
|
0.01
|
| Gain On Sale Of Security |
|
-0.01
+47.59%
|
-0.03
|
—
|
—
|
| Tax Provision |
|
-0.14
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Net Income From Continuing Operation Net Minority Interest |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Net Income From Continuing And Discontinued Operation |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Net Income Continuous Operations |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Normalized Income |
|
-9.83
+6.77%
|
-10.54
+48.96%
|
-20.66
-44.56%
|
-14.29
|
| Net Income Common Stockholders |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Diluted EPS |
|
-4.56
+90.48%
|
-47.88
+82.61%
|
-275.40
-29.11%
|
-213.30
|
| Basic EPS |
|
-4.56
+90.48%
|
-47.88
+82.61%
|
-275.40
-29.11%
|
-213.30
|
| Basic Average Shares |
|
2.16
+877.24%
|
0.22
+194.35%
|
0.07
+11.97%
|
0.07
|
| Diluted Average Shares |
|
2.16
+877.24%
|
0.22
+194.35%
|
0.07
+11.97%
|
0.07
|
| Diluted NI Availto Com Stockholders |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Other Taxes |
|
—
|
—
|
—
|
0.01
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
4.97
|
| Current Assets |
|
3.87
|
| Cash Cash Equivalents And Short Term Investments |
|
3.48
|
| Cash And Cash Equivalents |
|
3.48
|
| Other Short Term Investments |
|
—
|
| Receivables |
|
—
|
| Other Receivables |
|
—
|
| Accrued Interest Receivable |
|
—
|
| Prepaid Assets |
|
—
|
| Other Current Assets |
|
0.38
|
| Total Non Current Assets |
|
1.10
|
| Net PPE |
|
0.01
|
| Gross PPE |
|
0.01
|
| Accumulated Depreciation |
|
0.00
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.00
|
| Other Properties |
|
0.01
|
| Leases |
|
0.00
|
| Non Current Prepaid Assets |
|
1.09
|
| Total Liabilities Net Minority Interest |
|
1.80
|
| Current Liabilities |
|
1.80
|
| Payables And Accrued Expenses |
|
1.47
|
| Payables |
|
1.24
|
| Accounts Payable |
|
1.24
|
| Current Accrued Expenses |
|
0.22
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.01
|
| Current Debt And Capital Lease Obligation |
|
0.32
|
| Current Debt |
|
0.31
|
| Current Capital Lease Obligation |
|
0.01
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.00
|
| Stockholders Equity |
|
3.17
|
| Common Stock Equity |
|
1.58
|
| Capital Stock |
|
1.60
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
1.59
|
| Share Issued |
|
0.10
|
| Ordinary Shares Number |
|
0.10
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
207.79
|
| Retained Earnings |
|
-206.22
|
| Total Equity Gross Minority Interest |
|
3.17
|
| Total Capitalization |
|
3.17
|
| Working Capital |
|
2.07
|
| Invested Capital |
|
1.89
|
| Total Debt |
|
0.32
|
| Capital Lease Obligations |
|
0.01
|
| Net Tangible Assets |
|
3.17
|
| Tangible Book Value |
|
1.58
|
| Current Notes Payable |
|
0.31
|
| Preferred Stock Equity |
|
1.59
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-9.25
-7.55%
|
-8.60
-17.92%
|
-7.29
+52.12%
|
-15.23
|
| Cash Flow From Continuing Operating Activities |
|
-9.25
-7.55%
|
-8.60
-17.92%
|
-7.29
+52.12%
|
-15.23
|
| Net Income From Continuing Operations |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Depreciation Amortization Depletion |
|
—
|
0.00
-100.00%
|
0.03
-38.68%
|
0.04
|
| Depreciation And Amortization |
|
—
|
0.00
-100.00%
|
0.03
-38.68%
|
0.04
|
| Other Non Cash Items |
|
0.90
|
—
|
10.27
|
—
|
| Stock Based Compensation |
|
0.56
+7.69%
|
0.52
-49.25%
|
1.02
+37.00%
|
0.74
|
| Operating Gains Losses |
|
—
|
—
|
0.03
+373.22%
|
-0.01
|
| Gain Loss On Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.03
+373.22%
|
-0.01
|
| Change In Working Capital |
|
-0.86
-158.94%
|
1.45
-27.89%
|
2.02
+217.55%
|
-1.72
|
| Change In Receivables |
|
-0.05
|
0.00
|
0.00
-100.00%
|
0.01
|
| Change In Prepaid Assets |
|
-1.01
-163.98%
|
1.57
-21.32%
|
2.00
+205.33%
|
-1.90
|
| Change In Payables And Accrued Expense |
|
0.20
+269.57%
|
-0.12
-564.38%
|
0.03
-85.39%
|
0.18
|
| Change In Other Current Assets |
|
0.00
-100.00%
|
0.01
-97.09%
|
0.34
|
0.00
|
| Change In Other Current Liabilities |
|
0.00
+100.00%
|
-0.01
+97.17%
|
-0.35
|
—
|
| Investing Cash Flow |
|
—
|
0.00
+100.00%
|
-0.94
-710.50%
|
-0.12
|
| Cash Flow From Continuing Investing Activities |
|
—
|
0.00
+100.00%
|
-0.94
-710.50%
|
-0.12
|
| Net PPE Purchase And Sale |
|
—
|
0.00
-100.00%
|
0.06
+155.16%
|
-0.12
|
| Purchase Of PPE |
|
—
|
—
|
0.00
+100.00%
|
-0.13
|
| Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.06
+430.97%
|
0.01
|
| Capital Expenditure |
|
—
|
—
|
-1.00
-684.20%
|
-0.13
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
+100.00%
|
-1.00
|
0.00
|
| Purchase Of Intangibles |
|
—
|
0.00
+100.00%
|
-1.00
|
0.00
|
| Financing Cash Flow |
|
16.78
+180.68%
|
5.98
+2006.07%
|
0.28
+157.36%
|
-0.49
|
| Cash Flow From Continuing Financing Activities |
|
16.78
+180.68%
|
5.98
+2006.07%
|
0.28
+157.36%
|
-0.49
|
| Net Issuance Payments Of Debt |
|
-0.87
-25.90%
|
-0.69
-22.45%
|
-0.57
-0.33%
|
-0.56
|
| Issuance Of Debt |
|
2.46
|
0.00
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-3.33
-380.23%
|
-0.69
-22.45%
|
-0.57
-0.33%
|
-0.56
|
| Short Term Debt Issuance |
|
2.46
|
0.00
|
0.00
|
0.00
|
| Short Term Debt Payments |
|
-3.33
-380.23%
|
-0.69
-22.45%
|
-0.57
-0.33%
|
-0.56
|
| Net Short Term Debt Issuance |
|
-0.87
-25.90%
|
-0.69
-22.45%
|
-0.57
-0.33%
|
-0.56
|
| Net Common Stock Issuance |
|
2.63
-60.52%
|
6.67
+684.99%
|
0.85
+1126.64%
|
0.07
|
| Repurchase Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Changes In Cash |
|
7.53
+387.74%
|
-2.62
+67.03%
|
-7.94
+49.85%
|
-15.84
|
| Beginning Cash Position |
|
0.86
-75.17%
|
3.48
-69.51%
|
11.43
-58.09%
|
27.27
|
| End Cash Position |
|
8.40
+871.25%
|
0.86
-75.17%
|
3.48
-69.51%
|
11.43
|
| Free Cash Flow |
|
-9.25
-7.55%
|
-8.60
-3.70%
|
-8.29
+46.01%
|
-15.36
|
| Interest Paid Supplemental Data |
|
0.02
-25.06%
|
0.03
-2.49%
|
0.03
+229.29%
|
0.01
|
| Common Stock Issuance |
|
2.63
-60.52%
|
6.67
+684.99%
|
0.85
+1126.64%
|
0.07
|
| Issuance Of Capital Stock |
|
17.65
+164.60%
|
6.67
+684.99%
|
0.85
+1126.64%
|
0.07
|
| Net Preferred Stock Issuance |
|
15.02
|
0.00
|
—
|
0.00
|
| Preferred Stock Issuance |
|
15.02
|
0.00
|
—
|
—
|
| Preferred Stock Payments |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-13 View
- 8-K2026-03-31 View
- 10-K2026-03-16 View
- 8-K2026-03-11 View
- 8-K2026-01-22 View
- 8-K2026-01-20 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 8-K2025-12-15 View
- 8-K2025-11-12 View
- 10-Q2025-11-07 View
- 8-K2025-10-21 View
- 8-K2025-09-02 View
- 8-K2025-08-11 View
- 10-Q2025-08-08 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|